SCHEMBL4080076

SCHEMBL4080076

CC(O)C(=O)N[C@@H](CCCCN)C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 1/20 0.57
CPB2 Q96IY4 7/20 0.48
SLC6A5 Q9Y345 1/20 0.48
SLC15A2 Q16348 1/20 0.44
GSR P00390 1/20 0.44
GNPAT O15228 1/20 0.43
RNPEP Q9H4A4 1/20 0.43
ERAP2 Q6P179 1/20 0.43
ERAP1 Q9NZ08 1/20 0.43
LNPEP Q9UIQ6 1/20 0.43
SIRT6 Q8N6T7 1/20 0.42
SIRT1 Q96EB6 1/20 0.42
NMT2 O60551 1/20 0.42
NMT1 P30419 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30357165 1.00 FOLH1 (0.57) FOLH1CPB2SLC6A5SLC15A2GSR
SCHEMBL30357164 1.00 FOLH1 (0.57) FOLH1CPB2SLC6A5SLC15A2GSR
SCHEMBL4075195 1.00 FOLH1 (0.57) FOLH1CPB2SLC6A5SLC15A2GSR
SCHEMBL4078081 0.95 FOLH1 (0.50) FOLH1CPB2SLC6A5SLC15A2GNPAT
Lysine SCHEMBL4085092 0.92 GSR (0.59) FOLH1CPB2SLC6A5GSRERAP2
SCHEMBL9716630 0.88 FOLH1 (0.58) FOLH1CPB2SLC6A5SLC15A2GSR
SCHEMBL9716627 0.88 FOLH1 (0.58) FOLH1CPB2SLC6A5SLC15A2GSR
SCHEMBL1711242 0.86 FOLH1 (0.57) FOLH1CPB2SLC6A5SLC15A2GSR
SCHEMBL29563714 0.86 FOLH1 (0.57) FOLH1CPB2SLC6A5SLC15A2GSR
SCHEMBL16692902 0.86 FOLH1 (0.57) FOLH1CPB2SLC6A5SLC15A2GSR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114624362-A Kit for detecting advanced glycosylation end products in serum and application thereof 广东省中医院(广州中医药大学第二附属医院、广州中医药大学第二临床医学院、广东省中医药科学院) 2022-06-14 CN claimed
CN-119846215-A Application of EGLN1 lactonization as target in preparation of tumor diagnosis kit or therapeutic drug 广西医科大学附属肿瘤医院 2025-04-18 CN disclosed
CN-119345369-A Application of lactating modified histone H3 in preparation of products for treating and/or preventing pulmonary microvascular endothelial cell dysfunction 上海交通大学医学院附属瑞金医院 2025-01-24 CN disclosed
CN-118979060-A Method for encoding lysine acylated protein by high-efficiency gene 中国药科大学 2024-11-19 CN disclosed
CN-118879778-A System for inserting lactoylated lysine in mammal cells at fixed point and application thereof 南京中医药大学 2024-11-01 CN disclosed
CN-116825181-A Method for predicting non-histone lactic acid sites 吉林大学 2023-09-29 CN disclosed
CN-114657156-A Pyrrolysine aminoacyl-tRNA synthetase mutant and screening system and application thereof 南京中医药大学 2022-06-24 CN disclosed
CN-114624362-A Kit for detecting advanced glycosylation end products in serum and application thereof 广东省中医院(广州中医药大学第二附属医院、广州中医药大学第二临床医学院、广东省中医药科学院) 2022-06-14 CN disclosed
CN-114062298-A Quantitative detection method of furosine 保定蒙牛饮料有限公司 2022-02-18 CN disclosed
EP-1759595-B1 Flavour modulating substance GIVAUDAN NEDERLAND SERVICES B (NL) 2009-08-05 EP disclosed
US-20070054021-A1 Flavour modulating substance QUEST INTERNATIONAL SERVICES B.V. (NL) 2007-03-08 US disclosed
EP-1759595-A1 Flavour modulating substance Quest International Services B.V. (NL) 2007-03-07 EP disclosed
EP-1037611-A4 BIODEGRADABLE MIXED POLYMERIC MICELLES FOR GENE DELIVERY SAMYANG CORP (KR) 2006-09-20 EP disclosed
US-6638508-B2 Drug delivery; therapy for liver disorders YEDA RESEARCH AND DEVELOPMENT CO., LTD. (IL) 2003-10-28 US disclosed
US-20020009416-A1 MODIFIED AVIDIN-TYPE MOLECULES AS TARGETING AGENTS FOR THE LIVER AND CELLS OF THE RETICULOENDOTHELIAL SYSTEM YEDA RESEARCH AND DEVELOPMENT CO., LTD. (IL) 2002-01-24 US disclosed
EP-1037611-A1 BIODEGRADABLE MIXED POLYMERIC MICELLES FOR GENE DELIVERY Samyang Corporation (KR) 2000-09-27 EP disclosed
WO-1999029303-A1 BIODEGRADABLE MIXED POLYMERIC MICELLES FOR GENE DELIVERY SAMYANG CORPORATION (KR) 1999-06-17 WO disclosed
WO-1997022879-A1 MODIFIED AVIDIN-TYPE MOLECULES AS TARGETING AGENTS FOR THE LIVER AND CELLS OF THE RETICULOENDOTHELIAL SYSTEM YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 1997-06-26 WO disclosed